Tokyo Tape
Sign in
← J Frontier

Annual report

2934.TEDINET S100VB9U
Period2023-06-01 → 2024-05-31
Filed2025-02-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed

Amends S100UXGJ. Amended by S100VBDY (2025-02-27).

Key figures · 121
MetricValuePeriodScopeSource row
Revenue¥17.7bn2023-06-01 → 2024-05-31Cons.Net sales
Revenue¥16.8bn2022-06-01 → 2023-05-31Cons.Net sales
Revenue¥11.9bn2021-06-01 → 2022-05-31dCons.Net sales (5-year summary)
Operating income−¥553m2023-06-01 → 2024-05-31Cons.Operating income
Operating income−¥1.8bn2022-06-01 → 2023-05-31Cons.Operating income
Ordinary income−¥643m2023-06-01 → 2024-05-31Cons.Ordinary income
Ordinary income−¥1.8bn2022-06-01 → 2023-05-31Cons.Ordinary income
Ordinary income¥712m2021-06-01 → 2022-05-31dCons.Ordinary income loss (5-year summary)
Profit before tax−¥1.7bn2023-06-01 → 2024-05-31Cons.Income before income taxes
Profit before tax−¥1.8bn2022-06-01 → 2023-05-31Cons.Income before income taxes
Net income (owners)−¥2.1bn2023-06-01 → 2024-05-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥1.9bn2022-06-01 → 2023-05-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥401m2021-06-01 → 2022-05-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income−¥2.0bn2023-06-01 → 2024-05-31Cons.Profit loss
Net income−¥1.9bn2022-06-01 → 2023-05-31Cons.Profit loss
Total assets¥10.7bnat 2024-05-31Cons.Assets
Total assets¥7.2bnat 2023-05-31Cons.Assets
Total assets¥6.1bnat 2022-05-31dCons.Total assets (5-year summary)
Total liabilities¥9.1bnat 2024-05-31Cons.Liabilities
Total liabilities¥4.5bnat 2023-05-31Cons.Liabilities
Net assets / equity¥1.6bnat 2024-05-31Cons.Net assets
Net assets / equity¥2.7bnat 2023-05-31Cons.Net assets
Net assets / equity¥4.2bnat 2022-05-31dCons.Net assets
Cash and deposits¥1.8bnat 2024-05-31Cons.Cash and deposits
Cash and deposits¥1.6bnat 2023-05-31Cons.Cash and deposits
Cash & equivalents¥1.8bnat 2024-05-31Cons.Cash and cash equivalents
Cash & equivalents¥1.6bnat 2023-05-31Cons.Cash and cash equivalents
Cash & equivalents¥3.0bnat 2022-05-31dCons.Cash and cash equivalents
Operating cash flow−¥1.4bn2023-06-01 → 2024-05-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥1.8bn2022-06-01 → 2023-05-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥367m2021-06-01 → 2022-05-31dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥1.8bn2023-06-01 → 2024-05-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.1bn2022-06-01 → 2023-05-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥860m2021-06-01 → 2022-05-31dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow¥3.4bn2023-06-01 → 2024-05-31Cons.Net cash provided by used in financing activities
Financing cash flow¥1.5bn2022-06-01 → 2023-05-31Cons.Net cash provided by used in financing activities
Financing cash flow¥2.6bn2021-06-01 → 2022-05-31dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥-426.062023-06-01 → 2024-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-410.62022-06-01 → 2023-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥90.642021-06-01 → 2022-05-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥86.682021-06-01 → 2022-05-31dCons.Diluted earnings per share (5-year summary)
Net assets per share¥232.55at 2024-05-31Cons.Net assets per share (5-year summary)
Net assets per share¥525.78at 2023-05-31Cons.Net assets per share (5-year summary)
Net assets per share¥907.43at 2022-05-31dCons.Net assets per share (5-year summary)
Equity ratio10.8%at 2024-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio34.1%at 2023-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio67.8%at 2022-05-31dCons.Equity to asset ratio (5-year summary)
ROE9.7%2021-06-01 → 2022-05-31dCons.Rate of return on equity (5-year summary)
Employees315at 2024-05-31Cons.Number of employees
Employees255at 2023-05-31Cons.Number of employees
Employees278at 2022-05-31dCons.Number of employees
Revenue¥8.1bn2023-06-01 → 2024-05-31StandaloneNet sales
Revenue¥9.4bn2022-06-01 → 2023-05-31StandaloneNet sales
Revenue¥9.3bn2021-06-01 → 2022-05-31dStandaloneNet sales (5-year summary)
Revenue¥8.5bn2020-06-01 → 2021-05-31dStandaloneNet sales (5-year summary)
Revenue¥7.1bn2019-06-01 → 2020-05-31dStandaloneNet sales (5-year summary)
Operating income−¥139m2023-06-01 → 2024-05-31StandaloneOperating income
Operating income−¥1.7bn2022-06-01 → 2023-05-31StandaloneOperating income
Ordinary income−¥219m2023-06-01 → 2024-05-31StandaloneOrdinary income
Ordinary income−¥1.7bn2022-06-01 → 2023-05-31StandaloneOrdinary income
Ordinary income¥724m2021-06-01 → 2022-05-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥679m2020-06-01 → 2021-05-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥174m2019-06-01 → 2020-05-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.9bn2023-06-01 → 2024-05-31StandaloneIncome before income taxes
Profit before tax−¥1.7bn2022-06-01 → 2023-05-31StandaloneIncome before income taxes
Net income−¥2.1bn2023-06-01 → 2024-05-31StandaloneProfit loss
Net income−¥1.7bn2022-06-01 → 2023-05-31StandaloneProfit loss
Net income¥450m2021-06-01 → 2022-05-31dStandaloneNet income loss (5-year summary)
Net income¥425m2020-06-01 → 2021-05-31dStandaloneNet income loss (5-year summary)
Net income¥96m2019-06-01 → 2020-05-31dStandaloneNet income loss (5-year summary)
Total assets¥7.9bnat 2024-05-31StandaloneAssets
Total assets¥5.8bnat 2023-05-31StandaloneAssets
Total assets¥5.3bnat 2022-05-31dStandaloneTotal assets (5-year summary)
Total assets¥2.6bnat 2021-05-31dStandaloneTotal assets (5-year summary)
Total assets¥2.0bnat 2020-05-31dStandaloneTotal assets (5-year summary)
Total liabilities¥6.5bnat 2024-05-31StandaloneLiabilities
Total liabilities¥3.1bnat 2023-05-31StandaloneLiabilities
Net assets / equity¥1.4bnat 2024-05-31StandaloneNet assets
Net assets / equity¥2.8bnat 2023-05-31StandaloneNet assets
Net assets / equity¥4.2bnat 2022-05-31dStandaloneNet assets
Net assets / equity¥1.3bnat 2021-05-31dStandaloneNet assets (5-year summary)
Net assets / equity¥843mat 2020-05-31dStandaloneNet assets (5-year summary)
Cash and deposits¥657mat 2024-05-31StandaloneCash and deposits
Cash and deposits¥814mat 2023-05-31StandaloneCash and deposits
Cash & equivalents¥1.6bnat 2021-05-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥902mat 2020-05-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥831m2020-06-01 → 2021-05-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥218m2019-06-01 → 2020-05-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥8m2020-06-01 → 2021-05-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥165m2019-06-01 → 2020-05-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥94m2020-06-01 → 2021-05-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥99m2019-06-01 → 2020-05-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-438.42023-06-01 → 2024-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-357.082022-06-01 → 2023-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥101.912021-06-01 → 2022-05-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥110.752020-06-01 → 2021-05-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥25.122019-06-01 → 2020-05-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥97.452021-06-01 → 2022-05-31dStandaloneDiluted earnings per share (5-year summary)
Net assets per share¥280.35at 2024-05-31StandaloneNet assets per share (5-year summary)
Net assets per share¥589.16at 2023-05-31StandaloneNet assets per share (5-year summary)
Net assets per share¥918.35at 2022-05-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥329.99at 2021-05-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥219.25at 2020-05-31dStandaloneNet assets per share (5-year summary)
Equity ratio17.6%at 2024-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio47.4%at 2023-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio79.0%at 2022-05-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio48.8%at 2021-05-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio41.5%at 2020-05-31dStandaloneEquity to asset ratio (5-year summary)
ROE16.5%2021-06-01 → 2022-05-31dStandaloneRate of return on equity (5-year summary)
ROE40.3%2020-06-01 → 2021-05-31dStandaloneRate of return on equity (5-year summary)
ROE12.2%2019-06-01 → 2020-05-31dStandaloneRate of return on equity (5-year summary)
Shares issued5,137,046at 2024-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,892,098at 2023-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,757,616at 2022-05-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,918,500at 2021-05-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,918,500at 2020-05-31dStandaloneTotal number of issued shares (5-year summary)
Employees63at 2024-05-31StandaloneNumber of employees
Employees49at 2023-05-31StandaloneNumber of employees
Employees54at 2022-05-31dStandaloneNumber of employees
Employees46at 2021-05-31dStandaloneNumber of employees
Employees47at 2020-05-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 74
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2023-06-01 → 2024-05-31¥5m
Reconciling Itemsreconcilingdepreciation2023-06-01 → 2024-05-31¥2m
Reconciling Itemsreconcilingrevenue2023-06-01 → 2024-05-31−¥243m
Reconciling Itemsreconcilingrevenue intersegment2023-06-01 → 2024-05-31−¥243m
Reconciling Itemsreconcilingsegment assetsat 2024-05-31¥1.2bn
Reconciling Itemsreconcilingsegment profit2023-06-01 → 2024-05-31−¥588m
Healthcare Marketing Businessreportable segmentcapex2023-06-01 → 2024-05-31¥418m
Healthcare Marketing Businessreportable segmentdepreciation2023-06-01 → 2024-05-31¥10m
Healthcare Marketing Businessreportable segmentemployeesat 2024-05-3198 pure
Healthcare Marketing Businessreportable segmentrevenue2023-06-01 → 2024-05-31¥6.6bn
Healthcare Marketing Businessreportable segmentrevenue external2023-06-01 → 2024-05-31¥6.3bn
Healthcare Marketing Businessreportable segmentrevenue intersegment2023-06-01 → 2024-05-31¥232m
Healthcare Marketing Businessreportable segmentsegment assetsat 2024-05-31¥2.2bn
Healthcare Marketing Businessreportable segmentsegment profit2023-06-01 → 2024-05-31¥129m
Healthcare Sales Businessreportable segmentcapex2023-06-01 → 2024-05-31¥1.5bn
Healthcare Sales Businessreportable segmentdepreciation2023-06-01 → 2024-05-31¥3m
Healthcare Sales Businessreportable segmentemployeesat 2024-05-3176 pure
Healthcare Sales Businessreportable segmentrevenue2023-06-01 → 2024-05-31¥4.5bn
Healthcare Sales Businessreportable segmentrevenue external2023-06-01 → 2024-05-31¥4.5bn
Healthcare Sales Businessreportable segmentrevenue intersegment2023-06-01 → 2024-05-31¥993,000
Healthcare Sales Businessreportable segmentsegment assetsat 2024-05-31¥5.3bn
Healthcare Sales Businessreportable segmentsegment profit2023-06-01 → 2024-05-31¥163m
Medical Care Sales Businessreportable segmentcapex2023-06-01 → 2024-05-31¥85m
Medical Care Sales Businessreportable segmentdepreciation2023-06-01 → 2024-05-31¥32m
Medical Care Sales Businessreportable segmentemployeesat 2024-05-31125 pure
Medical Care Sales Businessreportable segmentrevenue2023-06-01 → 2024-05-31¥6.8bn
Medical Care Sales Businessreportable segmentrevenue external2023-06-01 → 2024-05-31¥6.8bn
Medical Care Sales Businessreportable segmentrevenue intersegment2023-06-01 → 2024-05-31¥9m
Medical Care Sales Businessreportable segmentsegment assetsat 2024-05-31¥1.9bn
Medical Care Sales Businessreportable segmentsegment profit2023-06-01 → 2024-05-31−¥258m
—segment totalemployeesat 2024-05-31315 pure
Total Of Reportable Segments And Otherssegment totalcapex2023-06-01 → 2024-05-31¥2.0bn
Total Of Reportable Segments And Otherssegment totaldepreciation2023-06-01 → 2024-05-31¥45m
Total Of Reportable Segments And Otherssegment totalrevenue2023-06-01 → 2024-05-31¥18.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-06-01 → 2024-05-31¥17.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-06-01 → 2024-05-31¥243m
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2024-05-31¥9.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-06-01 → 2024-05-31¥35m
Reconciling Itemsreconcilingcapex2022-06-01 → 2023-05-31¥2m
Reconciling Itemsreconcilingdepreciation2022-06-01 → 2023-05-31¥765,000
Reconciling Itemsreconcilingrevenue2022-06-01 → 2023-05-31−¥186m
Reconciling Itemsreconcilingrevenue intersegment2022-06-01 → 2023-05-31−¥186m
Reconciling Itemsreconcilingsegment assetsat 2023-05-31¥1.3bn
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2023-05-31−¥729m
Healthcare Marketing Businessreportable segmentcapex2022-06-01 → 2023-05-31¥4m
Healthcare Marketing Businessreportable segmentdepreciation2022-06-01 → 2023-05-31¥5m
Healthcare Marketing Businessreportable segmentrevenue2022-06-01 → 2023-05-31¥5.2bn
Healthcare Marketing Businessreportable segmentrevenue external2022-06-01 → 2023-05-31¥5.1bn
Healthcare Marketing Businessreportable segmentrevenue intersegment2022-06-01 → 2023-05-31¥185m
Healthcare Marketing Businessreportable segmentsegment assetsat 2023-05-31¥1.1bn
Healthcare Marketing Businessreportable segmentsegment profit2022-06-01 → 2023-05-31¥39m
Healthcare Sales Businessreportable segmentcapex2022-06-01 → 2023-05-31¥1.1bn
Healthcare Sales Businessreportable segmentdepreciation2022-06-01 → 2023-05-31¥4m
Healthcare Sales Businessreportable segmentrevenue2022-06-01 → 2023-05-31¥4.1bn
Healthcare Sales Businessreportable segmentrevenue external2022-06-01 → 2023-05-31¥4.1bn
Healthcare Sales Businessreportable segmentsegment assetsat 2023-05-31¥2.4bn
Healthcare Sales Businessreportable segmentsegment profit2022-06-01 → 2023-05-31−¥28m
Medical Care Sales Businessreportable segmentcapex2022-06-01 → 2023-05-31¥288m
Medical Care Sales Businessreportable segmentdepreciation2022-06-01 → 2023-05-31¥14m
Medical Care Sales Businessreportable segmentrevenue2022-06-01 → 2023-05-31¥7.7bn
Medical Care Sales Businessreportable segmentrevenue external2022-06-01 → 2023-05-31¥7.7bn
Medical Care Sales Businessreportable segmentrevenue intersegment2022-06-01 → 2023-05-31¥564,000
Medical Care Sales Businessreportable segmentsegment assetsat 2023-05-31¥2.4bn
Medical Care Sales Businessreportable segmentsegment profit2022-06-01 → 2023-05-31−¥1.1bn
Total Of Reportable Segments And Otherssegment totalcapex2022-06-01 → 2023-05-31¥1.4bn
Total Of Reportable Segments And Otherssegment totaldepreciation2022-06-01 → 2023-05-31¥23m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2023-05-31¥17.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2023-05-31¥16.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-06-01 → 2023-05-31¥186m
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2023-05-31¥5.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2023-05-31−¥1.1bn
Healthcare Marketing Businessreportable segmentemployeesat 2024-05-3112 pure
Healthcare Sales Businessreportable segmentemployeesat 2024-05-3122 pure
Medical Care Sales Businessreportable segmentemployeesat 2024-05-3115 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,590
ItemContextValueUnit
Capital surplusPrior1YearInstant3022845000JPY
Capital surplusCurrentYearInstant3398701000JPY
Retained earningsPrior1YearInstant-268964000JPY
Retained earningsCurrentYearInstant-2355391000JPY
Treasury stockPrior1YearInstant-452358000JPY
Treasury stockCurrentYearInstant-407564000JPY
Shareholders equityPrior1YearInstant2466984000JPY
Shareholders equityCurrentYearInstant1152704000JPY
Subscription rights to sharesPrior1YearInstant10125000JPY
Subscription rights to sharesCurrentYearInstant1465000JPY
Non controlling interestsPrior1YearInstant237684000JPY
Non controlling interestsCurrentYearInstant466729000JPY
Net assetsPrior1YearInstant2714794000JPY
Net assetsCurrentYearInstant1620898000JPY
Liabilities and net assetsPrior1YearInstant7240548000JPY
Liabilities and net assetsCurrentYearInstant10713787000JPY
Net salesPrior1YearDuration16844572000JPY
Net salesCurrentYearDuration17714904000JPY
Cost of salesPrior1YearDuration9727926000JPY
Cost of salesCurrentYearDuration9381649000JPY
Gross profitPrior1YearDuration7116646000JPY
Gross profitCurrentYearDuration8333255000JPY
Selling general and administrative expensesPrior1YearDuration8933130000JPY
Selling general and administrative expensesCurrentYearDuration8886256000JPY
Operating incomePrior1YearDuration-1816484000JPY
Operating incomeCurrentYearDuration-553001000JPY
Interest income noiPrior1YearDuration502000JPY
Interest income noiCurrentYearDuration1158000JPY
Dividends income noiPrior1YearDuration1000JPY
Dividends income noiCurrentYearDuration2000JPY
Foreign exchange gains noiPrior1YearDuration－JPY
Foreign exchange gains noiCurrentYearDuration1997000JPY
Subsidy income noi bountyPrior1YearDuration4438000JPY
Subsidy income noi bountyCurrentYearDuration758000JPY
Insurance premiums refunded cancellation noiPrior1YearDuration40000JPY
Insurance premiums refunded cancellation noiCurrentYearDuration6267000JPY
Other noiPrior1YearDuration1960000JPY
Other noiCurrentYearDuration2666000JPY
Non operating incomePrior1YearDuration6943000JPY
Non operating incomeCurrentYearDuration12851000JPY
Interest expenses noePrior1YearDuration11109000JPY
Interest expenses noeCurrentYearDuration27251000JPY
Share acquisition rights issuance costs noePrior1YearDuration9384000JPY
Share acquisition rights issuance costs noeCurrentYearDuration－JPY
Financing expenses noePrior1YearDuration－JPY
Financing expenses noeCurrentYearDuration30000000JPY
Commission fee noePrior1YearDuration－JPY
Commission fee noeCurrentYearDuration13684000JPY
Provision of allowance for doubtful accounts noePrior1YearDuration928000JPY
Provision of allowance for doubtful accounts noeCurrentYearDuration26372000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2023-05-31pass rounding
balance sheet identityconsolidated 2024-05-31pass rounding
balance sheet identitynon_consolidated 2023-05-31pass rounding
balance sheet identitynon_consolidated 2024-05-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net assetsconsolidated 2023-05-31pass
statement vs summary · net assetsconsolidated 2024-05-31pass
statement vs summary · net assetsnon_consolidated 2022-05-31pass
statement vs summary · net assetsnon_consolidated 2023-05-31pass
statement vs summary · net assetsnon_consolidated 2024-05-31pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2023-05-31pass
statement vs summary · net income attributable to parentconsolidated 2023-06-01/2024-05-31pass
statement vs summary · operating cash flowconsolidated 2022-06-01/2023-05-31pass
statement vs summary · operating cash flowconsolidated 2023-06-01/2024-05-31pass
statement vs summary · revenueconsolidated 2022-06-01/2023-05-31pass
statement vs summary · revenueconsolidated 2023-06-01/2024-05-31pass
statement vs summary · revenuenon_consolidated 2022-06-01/2023-05-31pass
statement vs summary · revenuenon_consolidated 2023-06-01/2024-05-31pass
statement vs summary · total assetsconsolidated 2023-05-31pass
statement vs summary · total assetsconsolidated 2024-05-31pass
statement vs summary · total assetsnon_consolidated 2023-05-31pass
statement vs summary · total assetsnon_consolidated 2024-05-31pass